Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.
Saved in:
| Title: | Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis. |
|---|---|
| Authors: | Sandler KA; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Cook RR; Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, Los Angeles, CA, USA., Ciezki JP; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA., Ross AE; Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Pomerantz MM; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Nguyen PL; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Shaikh T; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Stock RG; Department of Radiation Oncology, The Icahn School of Medicine at Mount Sinai, New York City, NY, USA., Merrick GS; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, WV, USA., Demanes DJ; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Abu-Isa EI; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Wedde TB; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Lilleby W; Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway., Krauss DJ; Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA., Shaw GK; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Alam R; Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Reddy CA; Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Song DY; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Klein EA; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA., Stephenson AJ; Department of Radiation Oncology, Cleveland Clinic, Cleveland, OH, USA., Tosoian JJ; Department of Urology, The James Buchanan Brady Urological Institute, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Hegde JV; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Yoo SM; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Fiano R; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, WV, USA., D'Amico AV; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Nickols NG; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA; Department of Radiation Oncology, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Aronson WJ; Department of Radiation Oncology, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA; Department of Urology, University of California, Los Angeles, Los Angeles, CA, USA., Sadeghi A; Department of Radiation Oncology, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Greco SC; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Deville C Jr; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., McNutt T; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., DeWeese TL; Department of Radiation Oncology and Molecular Radiation Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD, USA., Reiter RE; Department of Urology, University of California, Los Angeles, Los Angeles, CA, USA., Said JW; Department of Pathology, University of California, Los Angeles, Los Angeles, CA, USA., Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Kupelian PA; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., King CR; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA., Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu. |
| Source: | European urology [Eur Urol] 2020 Jan; Vol. 77 (1), pp. 3-10. Date of Electronic Publication: 2019 Apr 13. |
| Publication Type: | Comparative Study; Journal Article |
| Journal Info: | Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
